Skip to content
Skip to content
Open navigation

APRN Pharmacology Today: Treatment Of Major Depressive Disorders And Resistant Depression

Katie S. Adams

Regular Price: $79.00
ANA Member Price: $71.10
Online CE Expiration: 08/12/2019
3 Contact Hours
Presented by Ana

Register now for this online course and take the first steps toward safe prescribing practices.

List Price:
$79.00
ANA Member Price:
$71.10

For bulk or invoice purchases, please contact customerservice@ana.org

Course Details

Overview

Due to the widespread nature of depression, seasoned APRNs are likely to interact with patients dealing with depression or those taking antidepressant medications on a daily basis. In this new APRN Pharmacology Today online course, you will review pharmacotherapeutic options for the treatment of major depressive disorder (MDD), current clinical practice guideline recommendations for treatment of depression, and strategies to address treatment-resistant depression.

It’s time to have a better understanding of patients with depression. Join Katie S. Adams, Pharm.D., BCPP, BCPS, clinical pharmacy specialist in behavioral health at St. Mary’s Hospital in Richmond, Virginia, for this new self-paced online course.

This innovative pharmacology module includes case studies, self-assessment quizzes, and reflection to engage learners and illustrate drug contexts for major depressive disorder, along with information on available drug treatments for depression, current clinical practice guidelines, standards of care, and therapeutic options for patients whose first-line treatments fail. Register now for this online course and take the first steps toward safe prescribing practices.

List Price:
$79.00
ANA Member Price:
$71.10

For bulk or invoice purchases, please contact customerservice@ana.org

Key Learning Outcomes

After taking this interactive online course, you will be able to:

  • Describe diagnostic criteria for major depressive disorder (MDD), and characterize treatment-resistant depression.
  • Review current literature and guideline recommendations for the treatment of MDD.
  • Compare and contrast the available pharmacologic treatments for MDD
  • Formulate a treatment and monitoring plan for a patient with MDD.

Location Details

The American Nurses Association Center for Continuing Education and Professional Development is accredited as a provider of continuing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANCC Provider Number 0023

ANA is approved by the California Board of Registered Nursing, Provider Number CEP6178

Disclaimer

Use of these or any other course(s)/material(s) does not imply eligibility for certification or successful performance on any certification exam, nor is it a requirement to qualify for individual certification.

American Nurses Credentialing Center (ANCC) does not endorse any products or services.

You might also like

You are now leaving the American Nurses Foundation

The American Nurses Foundation is a separate charitable organization under Section 501(c)(3) of the Internal Revenue Code. The Foundation does not engage in political campaign activities or communications.

The Foundation expressly disclaims any political views or communications published on or accessible from this website.

Continue Cancel

Item(s) added to cart

Go to cart Continue Shopping